Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Soleno Therapeutics to Present DCCR Clinical Data for Prader-Willi Syndrome at 62nd Annual ESPE Meeting Quiver Quantitative, Inc. - Fri Nov 15, 1:20AM CST

Soleno Therapeutics will present DCCR clinical data for Prader-Willi syndrome at the upcoming ESPE Meeting in Liverpool.Quiver AI SummarySoleno Therapeutics, Inc. announced that it will present data from...

SLNO : 54.08 (-2.87%)
Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024 GlobeNewswire - Thu Nov 14, 3:05PM CST

SLNO : 54.08 (-2.87%)
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results GlobeNewswire - Wed Nov 6, 3:05PM CST

SLNO : 54.08 (-2.87%)
Soleno Therapeutics to Participate in Upcoming November Investor Conferences GlobeNewswire - Mon Oct 28, 7:00AM CDT

SLNO : 54.08 (-2.87%)
Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D. GlobeNewswire - Mon Oct 21, 7:00AM CDT

SLNO : 54.08 (-2.87%)
Why Soleno Therapeutics Stock Blasted 9% Higher Today Motley Fool - Tue Oct 8, 5:29PM CDT

The company's Prader-Willi treatment inched closer to FDA approval.

SLNO : 54.08 (-2.87%)
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome GlobeNewswire - Tue Oct 8, 7:30AM CDT

SLNO : 54.08 (-2.87%)
Charts, tickers, traders - iStock-1147352160
3 Top Small-Cap Tech Picks for Investors This Month Barchart - Fri Jul 26, 8:24AM CDT

Wall Street believes these three small companies have significant upside potential.

AMZN : 210.00 (-0.70%)
MSFT : 423.34 (-0.83%)
NVDA : 145.18 (-1.08%)
CHPT : 1.1100 (-0.89%)
$SPX : 5,949.17 (-0.60%)
VRDN : 21.30 (-1.57%)
SLNO : 54.08 (-2.87%)
Why Soleno Therapeutics Stock Is Skyrocketing Today Motley Fool - Mon Apr 29, 10:11AM CDT

The clinical-stage biotech company received great news from the FDA.

SLNO : 54.08 (-2.87%)
Why Soleno Therapeutics Stock Ticked Higher on Thursday Motley Fool - Thu Dec 21, 2023

The latest pundit take on the stock provided a good reason for bulls to snap it up.

SLNO : 54.08 (-2.87%)

Barchart Exclusives

Leverage the J-Hook Pattern for a Possible 122% Payout in EOG Resources (EOG) Barchart - 3 minutes ago
With fundamentals aligning favorably with the technicals, hydrocarbon energy play EOG stock should be on the speculator’s radar. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot